Effect of Vitamin E Supplementation on Plasma Lipid, Apolipoprotein and Lipoprotein Profiles in Patients on Peritoneal Dialysis and Hemodialysis

Atilla Uzum; Omer Toprak; M Gumustas; Senturk Ciftci; Saniye Sen

Nephro-Urology Monthly

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Effect of Vitamin E Supplementation on Plasma Lipid, Apolipoprotein and Lipoprotein Profiles in Patients on Peritoneal Dialysis and Hemodialysis

Author(s):

Atilla Uzum^1,*,

Omer Toprak²,

M Koray Gumustas³,

Senturk Ciftci⁴,

Saniye Sen⁴

1Department of Nephrology, Ataturk Training and Research Hospita, atillauzum@hotmail.com, Turkey

2Department of Nephrology, Balikesir State Hospital, Turkey

3Department of Biochemistry, Istanbul University Cerrahpasa Medical Faculty, Turkey

4Department of Biochemistry, Trakya University School of Medicine, Turkey

Nephro-Urology Monthly:Vol. 2, issue 2; 320-329

Article type:Research Article

Received:Jul 26, 2009

Accepted:Aug 11, 2009

How to Cite:Atilla UzumOmer ToprakM Koray GumustasSenturk CiftciSaniye SenEffect of Vitamin E Supplementation on Plasma Lipid, Apolipoprotein and Lipoprotein Profiles in Patients on Peritoneal Dialysis and Hemodialysis.Nephro-Urol Mon.2(2):320-329.

Abstract

Background and Aims: Dyslipidemia is one of the well known risk factor for cardiovascular disease in patients on dialysis. The aim of the present study was to assess the influence of vitamin E therapy on lipid profile in patients on hemodialysis (HD) and peritoneal dialysis (PD).

Methods: This was a case-control study. The study was performed on 34 HD patients, 13 PD patients and 22 healthy volunteers with a mean age of 45.57 ± 8.54 years. HD patients were divided into two groups, i.e. treatment (n=19) and control (n=15). Vitamin E was administered, 300 mg/day, to the HD treatment group and PD patients for 20 weeks. Plasma total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very-low density lipoprotein cholesterol, apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) were examined before and after vitamin E treatment.

Results: Before vitamin E treatment, the levels of high-density lipoprotein cholesterol were significantly lower in the HD patient group (35.91±10.54 mg/dl) and PD group (37.92±7.19 mg/dl) than the healthy group (44.27±8.33 mg/dl), (p=0.008). Before the treatment the levels of lipoprotein(a) were significantly higher in the HD group (28.12±10.85 mg/dl) and PD group (31.64±15.12 mg/dl) than the healthy group (22.09±9.05 mg/dl), (p=0.008). Lipid and lipoprotein levels in HD and PD groups were not changed significantly after vitamin E treatment.

Conclusions: Vitamin E supplementation is not effective on lipid and lipoprotein levels in patients on HD and PD.

Keywords

Full Text

Full text is available in PDF

comments